DMARDs (biologic) Giant Cell Arteritis Systemic vasculitis Treatment The cases we describe ... postprandial abdominal pain, bitemporal headache and blurring of vision. Temporal artery biopsy confirmed ...

There was no history of rheumatic fever, arthritis, venereal disease, tuberculosis or temporal headache. Five years previously she had noted the sudden onset of pain and weakness in the left arm ...

Differential diagnosis of pain in the face as the presenting ... The diagnosis of temporal arteritis was confirmed histologically (figure 1). On methylprednisolone treatment 100 mg per day he became ...

The following is a summary of “Simultaneous evaluation of restless leg syndrome, neuropathic pain, disease activity, and quality of life in patients with Takayasu arteritis: a cross-sectional study,” ...

providing effective pain relief without the risk of addiction that can come with opioids. Acute pain is short-term pain often caused by injuries, surgery, or trauma. Over 80 million Americans seek ...

The hallmark manifestations of PMR are pain and stiffness affecting the neck and shoulder ... has recently been evaluated in the treatment of patients with isolated PMR, GCA or both. Results on the ...

Suzetrigine is a nonaddictive alternative to opioids for pain relief. The U.S. Food and Drug Administration (FDA) has approved suzetrigine, the first drug in a new family of non-opioid painkillers ...

Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...

The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is the first non-opioid analgesic – or ...

NSAIDs-- or nonsteroidal anti-inflammatory drugs -- are among the most common pain relief medicines in the world. Every day more than 30 million Americans use them to soothe headaches, sprains ...